OBJECTIVE: To determine whether preoperative and/or postoperative central endothelial cell density (ECD) and its rate of decline postoperatively are predictive of graft failure caused by endothelial decompensation following penetrating keratoplasty to treat a moderate-risk condition, principally, Fuchs dystrophy or pseudophakic corneal edema. METHODS: In a subset of Cornea Donor Study participants, a central reading center determined preoperative and postoperative ECD from available specular images for 17 grafts that failed because of endothelial decompensation and 483 grafts that did not fail. RESULTS: Preoperative ECD was not predictive of graft failure caused by endothelial decompensation (P = .91). However, the 6-month ECD was predictive of subsequent failure (P < .001). Among those that had not failed within the first 6 months, the 5-year cumulative incidence (+/-95% confidence interval) of failure was 13% (+/-12%) for the 33 participants with a 6-month ECD of less than 1700 cells/mm(2) vs 2% (+/-3%) for the 137 participants with a 6-month ECD of 2500 cells/mm(2) or higher. After 5 years' follow-up, 40 of 277 participants (14%) with a clear graft had an ECD below 500 cells/mm(2). CONCLUSIONS: Preoperative ECD is unrelated to graft failure from endothelial decompensation, whereas there is a strong correlation of ECD at 6 months with graft failure from endothelial decompensation. A graft can remain clear after 5 years even when the ECD is below 500 cells/mm(2).
OBJECTIVE: To determine whether preoperative and/or postoperative central endothelial cell density (ECD) and its rate of decline postoperatively are predictive of graft failure caused by endothelial decompensation following penetrating keratoplasty to treat a moderate-risk condition, principally, Fuchs dystrophy or pseudophakic corneal edema. METHODS: In a subset of Cornea Donor Study participants, a central reading center determined preoperative and postoperative ECD from available specular images for 17 grafts that failed because of endothelial decompensation and 483 grafts that did not fail. RESULTS: Preoperative ECD was not predictive of graft failure caused by endothelial decompensation (P = .91). However, the 6-month ECD was predictive of subsequent failure (P < .001). Among those that had not failed within the first 6 months, the 5-year cumulative incidence (+/-95% confidence interval) of failure was 13% (+/-12%) for the 33 participants with a 6-month ECD of less than 1700 cells/mm(2) vs 2% (+/-3%) for the 137 participants with a 6-month ECD of 2500 cells/mm(2) or higher. After 5 years' follow-up, 40 of 277 participants (14%) with a clear graft had an ECD below 500 cells/mm(2). CONCLUSIONS: Preoperative ECD is unrelated to graft failure from endothelial decompensation, whereas there is a strong correlation of ECD at 6 months with graft failure from endothelial decompensation. A graft can remain clear after 5 years even when the ECD is below 500 cells/mm(2).
Authors: Mark A Terry; Neda Shamie; Edwin S Chen; Paul M Phillips; Karen L Hoar; Daniel J Friend Journal: Ophthalmology Date: 2008-12-16 Impact factor: 12.079
Authors: Jonathan H Lass; Beth Ann Benetz; Sanjay V Patel; Loretta B Szczotka-Flynn; Robert O'Brien; Allison R Ayala; Maureen G Maguire; Yassine J Daoud; Mark A Greiner; Sadeer B Hannush; W Barry Lee; Thomas F Mauger; Harry J Menegay; Mark D Mifflin; Michael B Raizman; Jennifer Rose-Nussbaumer; Robert L Schultze; Gregory A Schmidt; Alan Sugar; Mark A Terry; David D Verdier Journal: JAMA Ophthalmol Date: 2019-02-01 Impact factor: 7.389
Authors: Naomi Joseph; Chaitanya Kolluru; Beth A M Benetz; Harry J Menegay; Jonathan H Lass; David L Wilson Journal: J Med Imaging (Bellingham) Date: 2020-02-14
Authors: Jonathan H Lass; Roy W Beck; Beth Ann Benetz; Mariya Dontchev; Robin L Gal; Edward J Holland; Craig Kollman; Mark J Mannis; Francis Price; Irving Raber; Walter Stark; R Doyle Stulting; Alan Sugar Journal: Arch Ophthalmol Date: 2011-05-09
Authors: Tonya D Riddlesworth; Craig Kollman; Jonathan H Lass; Sanjay V Patel; R Doyle Stulting; Beth Ann Benetz; Robin L Gal; Roy W Beck Journal: Invest Ophthalmol Vis Sci Date: 2014-11-25 Impact factor: 4.799
Authors: Beth Ann Benetz; Jonathan H Lass; Robin L Gal; Alan Sugar; Harry Menegay; Mariya Dontchev; Craig Kollman; Roy W Beck; Mark J Mannis; Edward J Holland; Mark Gorovoy; Sadeer B Hannush; John E Bokosky; James W Caudill Journal: JAMA Ophthalmol Date: 2013-05 Impact factor: 7.389
Authors: David D Verdier; Alan Sugar; Keith Baratz; Roy Beck; Mariya Dontchev; Steven Dunn; Robin L Gal; Edward J Holland; Craig Kollman; Jonathan H Lass; Mark J Mannis; Jeffrey Penta Journal: Cornea Date: 2013-06 Impact factor: 2.651